Outlook Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	8.68	8.08	14.93	23.39	17.4	14.48
Cash & Short-Term Investments	8.68	8.08	14.93	23.39	17.4	14.48
Cash Growth	52.17%	-45.85%	-36.19%	34.46%	20.17%	15.49%
Accounts Receivable	0.11	1.49	-	-	-	-
Inventory	3.46	3.34	-	-	-	-
Other Current Assets	4.92	4.48	12.49	7.59	10.12	7.03
Total Current Assets	17.17	17.39	27.42	30.98	27.52	21.51
Net Property, Plant & Equipment	0.21	0.23	0.27	0.03	0.07	0.28
Long-Term Investments	0.51	0.55	0.69	0.79	0.8	0.85
Other Long-Term Assets	0.35	0.42	0.44	0.5	0.13	0.17
Total Assets	18.24	18.58	28.82	32.3	28.53	22.81
Accounts Payable	7.32	10.19	7.97	6.57	3.49	2.2
Accrued Expenses	5.02	5.62	5.09	4.6	5.28	3.58
Current Portion of Long-Term Debt	36.66	29.95	29.44	35.55	10.92	0.9
Current Portion of Leases	0.06	0.06	0.05	0	0.04	0.07
Total Current Liabilities	49.06	45.81	42.55	46.73	19.73	6.75
Long-Term Debt	-	-	-	-	-	10.89
Long-Term Leases	0.17	0.19	0.25	-	0	0.04
Other Long-Term Liabilities	7.56	4.77	59.1	0.01	0.06	0.52
Total Long-Term Liabilities	7.73	4.96	59.35	0.01	0.06	11.45
Total Liabilities	56.79	50.77	101.9	46.74	19.79	18.2
Common Stock	0.65	0.54	0.24	0.13	2.27	1.76
Additional Paid-in Capital	589.57	572.98	469.97	453.35	415.4	345.73
Retained Earnings	-628.77	-605.71	-543.28	-467.92	-408.94	-342.88
Shareholders' Equity	-38.55	-32.19	-73.08	-14.44	8.74	4.61
Total Liabilities & Equity	18.24	18.58	28.82	32.3	28.53	22.81
Total Debt	36.89	30.19	29.74	35.56	10.96	11.9
Net Cash (Debt)	-28.22	-22.11	-14.81	-12.16	6.44	2.57
Net Cash Growth	-	-	-	-	150.06%	-77.26%
Net Cash Per Share	-0.64	-0.64	-0.80	-0.97	0.61	0.34
Book Value	-38.55	-32.19	-73.08	-14.44	8.74	4.61
Book Value Per Share	-0.88	-0.93	-3.94	-1.15	0.82	0.60
Tangible Book Value	-38.55	-32.19	-73.08	-14.44	8.74	4.61
Tangible Book Value Per Share	-0.88	-0.93	-3.94	-1.15	0.82	0.60

Updated Feb 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q